10/06/2026
Excited to share our latest research published in AIDS Care! 📄✨
In our new study, “If condoms really aren't an option, then I would maybe push more for considering PrEP”: A qualitative exploration of Women’s Health Providers’ PrEP prescribing practices, we examined how healthcare clinicians navigate decision-making around prescribing PrEP to cisgender women.
Despite CDC guidelines recommending PrEP to all sexually active adults, our findings show that clinicians often view PrEP as a "last resort"—relying primarily on a risk-focused lens and condom negotiation before offering PrEP. To close the gap in HIV prevention for cisgender women, we need to address these clinician-level barriers and re-evaluate how PrEP is integrated into routine women's healthcare.
Huge thank you to my co-authors—Alison J. Goldberg, Taiylar Ball, Arielle Desir, Jonathan Purtle, Don Operario, and the entire team—for their collaboration on this work!
Read the full open-access article here: https://doi.org/10.1080/09540121.2026.2632722
Care
Cisgender women account for approximately 20% of new HIV diagnoses in the U.S., yet of those indicated for pre-exposure prophylaxis (PrEP) uptake is only 10%. Cisgender women are amenable to PrEP; ...